I hele behandlingsperioden opstod alvorlig neutropeni (< 500 celler/ mm3) hos 26% af patienterne, behandlet
Severe neutropenia (< 500 cells/ mm3) occurred in 26% of patients treated with Paxene during the entire treatment period.